- Trials with a EudraCT protocol (23)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
23 result(s) found for: paraplegia.
Displaying page 1 of 2.
EudraCT Number: 2019-002827-14 | Sponsor Protocol Number: TreatSPG11 | Start Date*: 2021-01-19 | |||||||||||
Sponsor Name:IRCCS Fondazione Stella Maris | |||||||||||||
Full Title: Phase 2 pharmacological experimental study to test the safety of miglustat in subjects with hereditary spastic paraplegia type 11 | |||||||||||||
Medical condition: Spastic paraparesis type 11 (SPG11), caused by mutations in spatacsin protein, is characterized by the association of peripheral neuropathy, parkinsonism, ataxia, cognitive impairment, hypotrophy o... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012073-34 | Sponsor Protocol Number: R0000063 | Start Date*: 2009-07-08 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait | |||||||||||||
Medical condition: Subjects with hereditary spastic paraparesis (HSP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005049-21 | Sponsor Protocol Number: MRZ-R-201212_01001_N_2 | Start Date*: 2017-01-12 |
Sponsor Name:LLC Merz Pharma, Russia | ||
Full Title: Multi-center Open Comparative Randomized Trial of Clinical and Neurophysiological Efficacy and Safety of Xeomin (Botulinum Toxin Type A) vs. Botox (Complex of Botulinum Toxin Type A and Hemaggluti... | ||
Medical condition: • Cerebral Palsy • Spastic Paraplegia and Hemiparesis • Equine and Equinovarus Foot Deformation | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-003309-12 | Sponsor Protocol Number: P100129 | Start Date*: 2011-11-10 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003184-11 | Sponsor Protocol Number: R0002820 | Start Date*: 2016-01-04 |
Sponsor Name:Radboud University Medical Centre | ||
Full Title: Functional effects of botulinum toxin in the hip adductors and subsequent exercise in patients with hereditary spastic paraplegia: a pilot RCT | ||
Medical condition: Hereditary Spastic Paraplegia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004509-11 | Sponsor Protocol Number: dopa_HSP | Start Date*: 2005-05-13 |
Sponsor Name:University hospital of the University of Ulm | ||
Full Title: Efficiency and tolerability of L-Dopa in patients with Hereditary Spastic Paraplegia (HSP) | ||
Medical condition: Hereditary spastic paraplegias (HSP) are a rare neurodegenerative group of disorders characterised by slowly progressive symmetric spastic paraparesis, distal pallhypaesthesia of the lower limbs, a... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000978-35 | Sponsor Protocol Number: STOP-SPG5 | Start Date*: 2015-10-21 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: Statin Treatment of Oxysterol Pathology in SPG5: a Randomized Controlled Trial -Proof of Principle | ||
Medical condition: SPG5 | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006113-34 | Sponsor Protocol Number: XAMNPIOAP2011 | Start Date*: 2013-10-24 |
Sponsor Name:AURORA PUJOL ONOFRE | ||
Full Title: Effect of pioglitazone administred to patients with Adrenomyeloneuropathy: A phase II, Singlearm, Monocentric Trial. | ||
Medical condition: X-linked adrenoleukodystrophy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001839-13 | Sponsor Protocol Number: AGO/2016/006 | Start Date*: 2016-06-07 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Influence of a bolus administration of ephedrine and phenylephrine on spinal oxygen saturation, measured with NIRS. | ||
Medical condition: Hypotension during surgery Paraplegia and/or paraparesis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000362-35 | Sponsor Protocol Number: AMSC-ALS-001 | Start Date*: 2012-03-29 | |||||||||||
Sponsor Name:Bioinova, s.r.o. | |||||||||||||
Full Title: A Prospective, Non-randomized, Open Label Study to Assess the Safety and the Efficacy of Autologous Multipotent Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis. | |||||||||||||
Medical condition: Amyotrophic lateral sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003930-10 | Sponsor Protocol Number: KEKU1 | Start Date*: 2018-01-12 |
Sponsor Name:Recherche et enseignement en douleur, anesthesie reanimation | ||
Full Title: KETAMINE'S EFFICIENCY IN THE TREATMENT OF CHRONIC PAIN WITH INFLAMMATORY COMPONENT: EXPLORING THE KYNURENIN PATHWAYS. A controlled, placebo-controlled, double-blind trial. | ||
Medical condition: The population selected is a spinal cord injury population with central neuropathic pain at the lesional or sub-lesion level, chronically (for more than three months) Adult, spinal cord injury (SCI... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001447-31 | Sponsor Protocol Number: 954 | Start Date*: 2014-01-14 |
Sponsor Name:Liverpool Heart and Chest Hospital NHS Foundation Trust | ||
Full Title: A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in ... | ||
Medical condition: Elevated cerebrospinal fluid pressure in patients undergoing thoracic-abdominal aortic repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005215-29 | Sponsor Protocol Number: 03-CoFactor | Start Date*: 2005-06-03 | |||||||||||
Sponsor Name:ADVENTRX Pharmaceuticals Inc | |||||||||||||
Full Title: A Multi-Center, Open Label, Parallel Group, Randomised, Phase IIB Clinical Trial to Evaluate the Safety and Efficacy of CoFactor and 5-FU versus Leucovorin and 5-FU in Subjects with Metastatic Colo... | |||||||||||||
Medical condition: Metastatic Colorectal Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001522-30 | Sponsor Protocol Number: RIMOFATSCI-2 | Start Date*: 2022-10-03 |
Sponsor Name:Fundación Hospital Nacional de Parapléjicos | ||
Full Title: Effects of a CB1 receptor reverse antagonist/agonist (Rimonabant) on wandering ability in patients with incomplete spinal cord injuries | ||
Medical condition: Possibility of improving wandering in patients. The effects of Rimonabant on other functional measures will be assessed and it will be confirmed that it is a safe treatment in the study population. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001599-18 | Sponsor Protocol Number: BAY 12-8039/11974 | Start Date*: 2006-11-03 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A prospective, randomized, double dummy, double blind, multinational, multicenter trial comparing the safety and efficacy of sequential (intravenous/oral) moxifloxacin 400 mg once daily to intraven... | |||||||||||||
Medical condition: complicated skin and skin structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) BE (Completed) LV (Completed) FR (Completed) GR (Completed) IE (Completed) HU (Completed) ES (Completed) NL (Prematurely Ended) AT (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001491-36 | Sponsor Protocol Number: Bay 12-8039/12670 | Start Date*: 2008-09-25 | |||||||||||
Sponsor Name:BAYER | |||||||||||||
Full Title: ''A prospective, randomized, open label, active comparator, multicenter, national trial to compare the efficacy and safety of sequential IV/PO moxifloxacin 400 mg once daily versus IV amoxicillin/c... | |||||||||||||
Medical condition: cSSSIs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005786-23 | Sponsor Protocol Number: XCEL-SCI-01 | Start Date*: 2016-04-20 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A phase I/IIa, randomized, double-blind, single-dose, placebo controlled, two-way crossover clinical trial to assess the safety and to obtain efficacy data in intrathecal administration of expanded... | |||||||||||||
Medical condition: Chronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002805-13 | Sponsor Protocol Number: LTF-304 | Start Date*: 2015-11-27 | |||||||||||
Sponsor Name:bluebird bio, Inc | |||||||||||||
Full Title: Longterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001953-10 | Sponsor Protocol Number: ALD-102 | Start Date*: 2013-12-13 | |||||||||||
Sponsor Name:bluebird bio, Inc. | |||||||||||||
Full Title: A phase 2/3 study of the efficacy and safety of hematopoietic stem cells transduced with Lenti D lentiviral vector for the treatment of cerebral adrenoleukodystrophy (CALD) | |||||||||||||
Medical condition: Cerebral Adrenoleukodystrophy (CALD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) DE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024084-40 | Sponsor Protocol Number: XAMNANTIOXAP2010 | Start Date*: 2011-06-30 | |||||||||||
Sponsor Name:Aurora Pujol Onofre | |||||||||||||
Full Title: Ensayo clínico en adrenomieloneuropatía (AMN): validación de biomarcadores de estrés oxidativo, eficacia y tolerancia de la combinación de antioxidantes N-acetilcisteína, ácido lipoico y vitamina E | |||||||||||||
Medical condition: Adrenoleucodistrofia ligada al X (XALD), fenotipo Adrenomieloneuropatía (AMN). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.